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A norexia nervosa (AN) is an eating disorder char-acterized by severe weight loss and malnutrition 
[1].  It is a comorbid disorder and has the highest mortal-
ity rate among all mental disorders [2 , 3].  Hypoglycemic 
coma in patients with AN has rarely been reported,  but 
it is clinically important because it is potentially fatal 
[4-7] and its precise mechanism of onset remains 
unknown.  We present a case of AN with recurrent 
hypoglycemic coma.  It is interesting that serum gluca-
gon and insulin-like growth factor-I (IGF)-I levels in 
this case were extremely low,  indicating an impaired 
glucose metabolism.  This case suggests that impair-
ment of the hepatic glucose metabolism is likely to be 
associated with exacerbation of hypoglycemia in 
patients with AN.
Case Report
A 36-year-old woman with AN presented with 
hypoglycemic coma and was transferred to the psychi-
atric ward of our hospital.  She had started to reduce her 
body weight 19 years earlier and developed amenor-
rhea.  After she married and gave birth to a child fol-
lowing Kaufmann’s treatment at a body weight of 42 kg 
eight years ago,  her excessive exercise and reduction of 
food intake were exacerbated.  She first experienced a 
reversible hypoglycemic coma with a blood glucose 
level of 12 mg/dL while doing aerobics 2 years ago,  
when her body weight was 28.6 kg and her body mass 
index (BMI) was 11.9 kg/m2.  Because she had emacia-
tion,  fear of weight gain,  and body image disturbance,  
she was diagnosed with AN based on the Diagnostic 
and Statistical Manual of Mental Disorders (Fifth 
Edition).  She experienced similar episodes of hypogly-
cemic coma that resulted in hospitalization five times.  
Her other past medical history and her familial medical 
history were unremarkable.  Her prescribed medicines 
at the time of admission to our hospital were ursode-
oxycholic acid (300 mg),  rikkunshi-to (7.5 g),  clotiaze-
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Anorexia nervosa (AN) is occasionally complicated with hypoglycemic coma,  which may cause sudden death by 
unknown mechanisms.  We present the case of a 36-year-old woman with recurrent comas and a nineteen-year 
history of AN.  She was found in a coma with remarkable hypoglycemia (28 mg/dL).  Her BMI was 11.1 kg/m2.  
Endocrine workup revealed extremely low serum levels of glucagon,  IGF-I and insulin.  Asymptomatic hypo-
glycemia occurred with liver injury in the refeeding process.  An aberrant glucose metabolism due to liver dam-
age might have been involved in her susceptibility to hypoglycemia.  This case suggests a possible mechanism of 
hypoglycemic coma in AN.
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pam (5 mg) and eszopiclone (1 mg).  She had no history 
of foods or complementary therapies that could cause 
hepatotoxicity.
The patient had a two-week history of general 
fatigue and progressive anorexia.  Three days before 
admission to our hospital,  she was found in a coma and 
transported to a nearby hospital.  Her blood glucose 
level at that time was 28 mg/dL.  She became alert after 
the intravenous administration of glucose,  but her state 
of malnutrition was life-threatening and aggressive care 
was needed.  She was transferred to our hospital for 
thorough investigation and further treatment.  On 
admission,  her height,  body weight,  and BMI were 
155 cm,  26.7 kg,  and 11.1 kg/m2,  respectively.  She was 
drowsy and had hypothermia (body temperature of 
35.2°C).  Her other vital signs were as follows: blood 
pressure,  112/86 mmHg; heart rate,  76/min and reg-
ular; and saturation of percutaneous oxygen at room 
air,  94%.  Physical assessment revealed anemia,  dehy-
dration,  and severe emaciation,  but jaundice,  goiter 
and edema were not observed.  There were no signs of 
respiratory or cardiac disorders.
Laboratory data showed pancytopenia with macro-
cytic anemia and moderately elevated serum levels of 
liver enzymes and metabolites,  reflecting malnutrition 
(Table 1).  An endocrine workup revealed an impaired 
glycometabolic system with extremely low serum levels 
of glucagon (< 3.5 pg/mL; normal range: 5.4-55.0) and 
IGF-I (< 7 ng/mL; normal range: 109-265) (Table 2).  
The patient’s serum levels of C-peptide (0.52 ng/mL) and 
immunoreactive insulin (IRI; 0.7 μU/mL) were also 
decreased,  while her serum levels of growth hormone 
(GH; 32.1 ng/mL),  adrenocorticotropic hormone 
(ACTH; 22.8 pg/mL),  and cortisol (23.1 μg/dL) were 
elevated (Table 2).  The results of an electrocardiogram 
and a chest X-ray were normal.  Ultrasonography and 
computed tomography (CT) showed no specific find-
ings of the liver.  There were no signs of pleural effusion 
or ascites.  No pathological findings that might have 
caused a coma were detected by brain CT or magnetic 
resonance imaging.  Electroencephalography showed 
that her basal brain wave was a medium alpha wave with 
low amplitude,  and no abnormalities were detected.
Nutritional therapy including the oral ingestion of 
200 kcal (29.3 g glucose,  7.5 g amino acid,  and 5.6 g 
lipid) a day and the intravenous infusion of 1,000 mL 
containing 250 kcal (62.5 g glucose) for 24 h continu-
ously with supplementation of potassium,  inorganic 
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Table 1　 Laboratory data on admission
Hematological data Units (normal range)
White blood cells 2330 ↓ /μL (3300-8600)
Hemoglobin 10.5 ↓ g/dL (11.6-14.8)
MCV 109.9 ↑ fl (83.6-98.2)
Reticlocyte 1.30 % (0.7-2.0)
Platelets 74000 ↓ /μL (158000-348000)
Biochemical data Units (normal range)
Total protein 4.9 ↓ g/dL (6.6-8.1)
Albumin 2.9 ↓ g/dL (4.1-5.1)
Prealbumin 8 ↓ mg/dL (22-40)
Blood urea nitrogen 15.1 mg/dL (8-20)
Creatinine 0.46 mg/dL (0.46-0.79)
Sodium 140 mmol/L (138-145)
Potassium 4.3 mmol/L (3.6-4.8)
Chloride 102 mmol/L (101-108)
Calcium 7.7 ↓ mg/dL (8.8-10.1)
Magnesium 1.7 ↓ mg/dL (2.0-2.5)
Inorganic phosphate 2.5 ↓ mg/dL (2.7-4.6)
Zinc 50 ↓ μg/dL (80-130)
AST 127 ↑ U/L (13-30)
ALT 81 ↑ U/L (7-23)
ALP (JSCC method) 494 ↑ U/L (106-322)
γ-GTP 74 ↑ U/L (9-32)
Total bilirubin 0.9 mg/dL (0.4-1.5)
Creatine kinase 86 U/L (41-153)
Amylase 325 ↑ mg/dL (44-132)
Cholinesterase 117 ↓ U/L (201-421)
Total cholesterol 133 ↓ mg/dL (142-248)
C-reactive protein 0.04 mg/dL (≦0.14)
Hemoglobin A1c 4.8 ↓ % (4.9-6.0)
Total keton bodies 24 μmol/L (0-131)
Acetoacetic acid 9 μmol/L (0-55)
3-Hydroxybutyric acid 15 μmol/L (0-85)
FFA 35 ↓ μEq/L (140-850)
Ferritin 784.0 ↑ ng/mL (6.2-138.0)
Iron 66 μg/dL (40-188)
TIBC 134 ↓ μg/dL (240-430)
UIBC 68 ↓ μg/dL (180-280)
Folic acid 7.57 ng/mL (3.89-26.8)
Vitamin B12 61297 ↑ pg/mL (197-771)
Coagulation
PT-INR 1.19
ALP,  alkaline phosphatase; ALT,  alanine aminotransferase; AST,  
aspartate aminotransferase; FFA,  free fatty acid; γ-GTP,  γ-glu-
tamyl transpeptidase; JSCC method,  Japan Society of Clinical 
Chemistry reference method; PT-INR,  prothorombin time-interna-
tional normalized ratio; MCV,  mean corpuscular volume; TIBC,  
total iron binding capacity; UIBC,  unsaturated iron binding capac-
ity.
phosphate (1,200 mg oral sodium phosphate),  magne-
sium,  and a cocktail of vitamin B was commenced.  Fat 
emulsion,  to which she had an allergy,  was not used.  
As shown in Fig. 1,  her hypoglycemia had improved 
4 days after admission.  However,  liver injury occurred 
and her serum levels of aminotransferase (AST) (331  
U/L) and alanine aminotransferase (ALT; 287 U/L) 
were elevated 3 weeks after admission (Fig. 1).  Serologic 
tests for hepatitis B and C were negative and there was 
no evidence of alcohol abuse or use of hepatotoxic 
drugs.  During the same period when the liver injury 
occurred,  asymptomatic hypoglycemia with a blood 
glucose level of about 50 mg/dL was observed.  The 
hypoglycemia improved as the liver injury was amelio-
rated due to refeeding.  The patient’s oral ingestion was 
then increased to 2,400 kcal a day without intravenous 
infusion,  and nutritional therapy for 7 weeks not only 
improved her complicated refeeding condition but also 
ameliorated endocrinological suppression.  Insulin 
secretion,  the GH/IGF-I axis,  and thyroid function were 
ameliorated (Table 2).  However,  the patient’s intracta-
ble anorexic symptoms such as vomiting and excessive 
exercise interrupted body weight gain (Fig. 1).  On Day 
36,  her body weight had decreased to 27.2 kg,  although 
there was no clear reason for this and no use of diuretic 
agents had been noted.  Nutritional therapy did not 
improve estradiol secretion possibly due to insufficient 
body weight gain (Table 2).  The patient was discharged 
with a weight gain to 28.3 kg (BMI,  11.8 kg/m2).
Discussion
Although moderate hypoglycemia in AN cases is 
often encountered [8],  episodes of recurring hypogly-
cemic coma in AN patients are very rare but can be fatal 
[4-7].  The precise mechanism underlying the develop-
ment of severe hypoglycemia in AN patients remains 
unclear.  Of interest,  the present case had an impaired 
hepatic glucose metabolism as indicated by undetect-
able glucagon and IGF-I levels.  Moderately elevated 
levels of hepatic enzymes were also observed,  reflecting 
liver injury due to malnutrition [9 , 10].  During the 
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Table 2　 Endocrine data before and after nutritional recovery in the patient
Before recovery After recovery Units (normal range)
FPG 52 84 mg/dL (73-109)
Hormones related to glucose metabolism
C-peptide 0.52 1.07 ng/mL (0.74-3.18)
IRI 0.7 5.2 μU/mL (2.1-19.0)
Glucagon <3.5 7.3 pg/mL (5.4-55.0)
ACTH 22.8 23.8 pg/mL (7.2-63.3)
Cortisol 23.1 11.0 μg/dL (7.07-19.6)
GH 32.1 2.78 ng/mL (0.13-9.88)
IGF-I <7.00 54.0 ng/mL (109-265)
Adrenaline 0.19 <0.01 ng/mL (<0.1)
Noradrenaline 0.75 0.25 ng/mL (0.1-0.5)
Dopamine 0.02 <0.01 ng/mL (<0.03)
Other hormones
TSH 36.7 11.7 μU/mL (0.33-4.05)
FT4 0.95 0.56 ng/dL (0.97-1.69)
FT3 1.34 3.39 pg/mL (2.30-4.00)
LH 0.1 0.3 mIU/mL (1.1-12.1)
FSH 0.5 3.5 mIU/mL (2.6-11.9)
E2 <0.5 <0.5 pg/mL (28.8-196.8)
PRL 11.9 42.3 ng/mL (1.6-21.9)
The blood sampling was performed in the morning.
ACTH,  adrenocorticotropic hormone; E2,  estradiol; FPG,  fasting plasma glucose; FSH,  follicle-stimulating hormone; FT3,  free triiodo-
thyronine; FT4,  free thyroxine; GH,  growth hormone; IGF-I,  insulin-like growth factor-I; IRI,  immunoreactive insulin; LH,  luteinizing hor-
mone; PRL,  prolactin; TSH,  thyroid-stimulating hormone.
patient’s clinical course,  her liver injury was exacer-
bated in the refeeding process with asymptomatic hypo-
glycemia (Fig. 1).  After she had recovered from the liver 
injury and malnutrition,  she no longer presented with 
hypoglycemia and her endocrinological abnormality 
including extremely decreased levels of serum glucagon 
and IGF-I was reversed,  suggesting that the primary 
cause of the hypoglycemia was related to her liver dam-
age (Table 2).
Regarding the pathophysiology of hypoglycemic 
coma in AN patients,  previous studies have suggested 
several different mechanisms,  including impaired glu-
coneogenesis due to infection [11] or liver injury 
[9 , 10 , 12-14],  insufficient glucagon function [15-17],  
lack of glucose and lipid accumulation [7 , 18],  and 
reactive hypoglycemia [19-21].  Patients with AN also 
tend to manifest starvation-induced hepatitis,  which is 
a high risk for hypoglycemia and can be fatal due to 
depleted glycogen stores and impaired gluconeogenesis 
in severe cases [8 , 10 , 22].  In addition,  since our patient 
experienced recurrent hypoglycemia,  hypoglycemia- 
associated autonomic failure (HAAF) might have con-
tributed to her particular pathology [23].  HAAF is 
typically seen in diabetic patients with a compromised 
defense against hypoglycemia,  and those patients are 
unaware of hypoglycemia with a lack of glucose count-
er-regulations including glucagon secretion [23].
Excessive activation of liver autophagy is a key con-
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Fig. 1　 Clinical course.  Hypoglycemic events (BG <20 mg/dL) occurred 5 times over the 2-year period before admission.  Asymptomatic 
hypoglycemia on admission was treated by nutritional supplementation.  After transient increases in serum AST and ALT levels,  hypoglyce-
mia and liver function gradually improved with continued nutritional rehabilitation.  Endocrine tests were performed on the indicated 
dates; the results are shown in Table 2.  ALT,  alanine aminotransferase; AST,  aminotransferase; BG,  blood glucose; BW,  body 
weight; iP,  inorganic phosphate.
tributor to liver dysfunction in people in a starved con-
dition [24].  On the other hand,  during the refeeding 
process,  elevated serum levels of aminotransferases in 
AN patients are considered to be due to hepatic steato-
sis [25].  Imaging tests such as ultrasound (US) and CT 
are useful for determining whether liver dysfunction is 
caused by starvation or refeeding [26].  The present case 
showed bimodal elevations of transaminases on admis-
sion and in the refeeding period,  as shown in Fig. 1.  
Since US on admission showed no signs of fatty liver,  
her liver dysfunction was considered to be due to star-
vation at that time,  while the liver injury during the 
refeeding process was thought to have been caused by 
refeeding syndrome.  Also,  carnitine deficiency could 
have been involved in the deterioration of hypoglyce-
mia before and after the commencement of nutritional 
therapy [27 , 28].  The present case showed no clear evi-
dence of the development of an infectious disease or 
reactive hypoglycemia,  but did show liver injury,  aber-
rant hepatic glycometabolism,  and lack of glucose and 
lipid accumulation.
Regarding endocrine characteristics in our patient 
(Table 2),  hypercortisolemia (increased ACTH and 
cortisol secretion),  GH resistance (low IGF-I and 
increased GH),  and hypogonadotropic hypogonadism 
(low follicle-stimulating hormone and luteinizing hor-
mone levels) were present,  suggesting underlying 
severe malnutrition consistent with AN [29].  The 
hypothalamic-pituitary-adrenal axis is chronically stim-
ulated due to the stress of starvation in anorectic 
patients,  and cortisol works as a counter-regulatory 
hormone to hypoglycemia [29 , 30].  Another hormone 
acting in a counter-regulatory way to insulin is cate-
cholamine,  whose turnover is impaired primarily in 
patients with AN [31],  while those hormones were 
slightly elevated in our case.  An examination of our 
patient’s thyroid function showed an inappropriately 
increased level of thyroid-stimulating hormone (TSH) 
with low levels of free triiodothyronine (T3) and free 
thyroxine; these findings are inconsistent with a typical 
state of malnutrition [29].  Since serum anti-thyroid 
peroxidase and anti-thyroglobulin antibodies were neg-
ative,  her hypothyroidism was presumed to be caused 
by silent thyroiditis and/or low T3 syndrome associated 
with an inappropriately high secretion of TSH [32].  In 
addition,  iodine deficiency due to anorexia might have 
been involved in the development of hypothyroidism,  
though urinary iodine excretion was not evaluated in 
this case.
It is noteworthy that both glucagon secretion and 
insulin secretion are impaired in anorectic patients [17].  
Glucagon is known to have the capabilities of hepatic 
gluconeogenesis,  glycogenolysis,  and glucose toler-
ance.  It has been shown that the recovery of plasma 
glucose levels from insulin-induced hypoglycemia is 
impaired in AN patients due to insufficient glucagon 
secretion and that recovery is possible by nutritional 
treatment [15].  It has also been reported that patients 
with AN had greatly reduced sensitivity in glucagon-in-
duced hepatic glycogenolysis [16].  The GH/IGF-I axis 
depends mainly on nutritional status.  Undernutrition 
induces GH resistance,  which is reversed by refeeding 
and weight recovery [29].  GH elevation may serve to 
maintain euglycemia by gluconeogenesis and lipolysis 
[29].
In summary,  we have presented a case of AN with 
recurrent hypoglycemic coma.  The patient had revers-
ible asymptomatic hypoglycemia coincident with liver 
injury and an aberrant hepatic glucose metabolism,  
which were considered to have played a key role in the 
induction of hypoglycemia.  Of note,  it was conceivably 
an important factor in the patient’s susceptibility to 
hypoglycemia that she had a very low BMI and a long-
term state of malnutrition,  inducing the lack of glucose 
and lipid accumulation.  This case suggests a possible 
underlying mechanism of the development of hypogly-
cemic coma in patients with AN,  although the detailed 
mechanism has yet to be elucidated.  Clinicians should 
pay particular attention to asymptomatic hypoglycemia,  
especially when there is hepatic damage,  in anorectic 
patients.
Acknowledgments.　Written informed consent was obtained from the 
patient to publish this case report.
References
 1. Treasure J,  Zipfel S,  Micali N,  Wade T,  Stice E,  Claudino A,  
Schmidt U,  Frank GK,  Bulik CM and Wentz E: Anorexia nervosa.  
Nat Rev Dis Primers (2015) 1: 15074.
 2. Bruch H: Death in anorexia nervosa.  Psychosom Med (1971) 33:  
135-144.
 3. Smink FR,  van Hoeken D and Hoek HW: Epidemiology of eating 
disorders: incidence,  prevalence and mortality rates.  Curr Psychiatry 
Rep (2012) 14: 406-414.
 4. Zalin AM and Lant AF: Anorexia nervosa presenting as reversible 
hypoglycaemic coma.  J R Soc Med (1984) 77: 193-195.
 5. Ratcliffe PJ and Bevan JS: Severe hypoglycaemia and sudden 
October 2021 Hypoglycemic Coma in Anorexia Nervosa 635
death in anorexia nervosa.  Psychol Med (1985) 15: 679-681.
 6. Smith J: Hypoglycaemic coma associated with anorexia nervosa.  
Aust N Z J Psychiatry (1988) 22: 448-453.
 7. Rich LM,  Caine MR,  Findling JW and Shaker JL: Hypoglycemic 
coma in anorexia nervosa.  Case report and review of the literature.  
Arch Intern Med (1990) 150: 894-895.
 8. Gaudiani JL,  Sabel AL,  Mascolo M and Mehler PS: Severe 
anorexia nervosa: outcomes from a medical stabilization unit.  Int J 
Eat Disord (2012) 45: 85-92.
 9. Furuta S,  Ozawa Y,  Maejima K,  Tashiro H,  Kitahora T,  Hasegawa K,  
Kuroda S and Ikuta N: Anorexia nervosa with severe liver dysfunc-
tion and subsequent critical complications.  Intern Med (1999) 38:  
575-579.
10. Rosen E,  Bakshi N,  Watters A,  Rosen HR and Mehler PS:  
Hepatic Complications of Anorexia Nervosa.  Dig Dis Sci (2017) 
62: 2977-2981.
11. Copeland PM and Herzog DB: Hypoglycemia and death in 
anorexia nervosa.  Psychother Psychosom (1987) 48: 146-150.
12. Yamada Y,  Fushimi H,  Inoue T,  Nishinaka K and Kameyama M:  
Anorexia nervosa with recurrent hypoglycemic coma and cerebral 
hemorrhage.  Intern Med (1996) 35: 560-563.
13. Yoshida S,  Shimada M,  Kornek M,  Kim SJ,  Shimada K and 
Schuppan D: Elevated transaminases as a predictor of coma in a 
patient with anorexia nervosa: a case report and review of the lit-
erature.  J Med Case Rep (2010) 4: 307.
14. Sakurai-Chin C,  Ito N,  Taguchi M,  Miyakawa M,  Takeshita A and 
Takeuchi Y: Hypoglycemic coma in a patient with anorexia ner-
vosa coincident with acute exacerbation of liver injury induced by 
oral intake of nutrients.  Intern Med (2010) 49: 1553-1556.
15. Fujii S,  Tamai H,  Kumai M,  Takaichi Y,  Nakagawa T and Aoki TT:  
Impaired glucagon secretion to insulin-induced hypoglycemia in 
anorexia nervosa.  Acta Endocrinol (Copenh) (1989) 120: 610-615.
16. Yanai H,  Yoshida H,  Tomono Y and Tada N: Severe hypoglyce-
mia in a patient with anorexia nervosa.  Eat Weight Disord (2008) 
13: e1-3.
17. Kumai M,  Tamai H,  Fujii S,  Nakagawa T and Aoki TT: Glucagon 
secretion in anorexia nervosa.  Am J Clin Nutr (1988) 47: 239-242.
18. Fonseca V,  Ball S,  Marks V and Havard CW: Hypoglycaemia 
associated with anorexia nervosa.  Postgrad Med J (1991) 67:  
460-461.
19. Inui A,  Uemoto M,  Seki W,  Ueno N,  Morita S,  Baba S and 
Kasuga M: Rebound hypoglycaemia after intravenous glucose in 
anorexia nervosa.  Lancet (1996) 347: 323-324.
20. Yasuhara D,  Deguchi D,  Tsutsui J,  Nagai N,  Nozoe S and Naruo T:  
A characteristic reactive hypoglycemia induced by rapid change of 
eating behavior in anorexia nervosa: a case report.  Int J Eat 
Disord (2003) 34: 273-277.
21. Yasuhara D,  Kojima S,  Naruo T and Inui A: Relationship between 
pretreatment laboratory-measured episodes of reactive hypoglyce-
mia and short-term weight restoration in anorexia nervosa: a pre-
liminary study.  Psychoneuroendocrinology (2006) 31: 452-458.
22. Rosen E,  Sabel AL,  Brinton JT,  Catanach B,  Gaudiani JL and 
Mehler PS: Liver dysfunction in patients with severe anorexia ner-
vosa.  Int J Eat Disord (2016) 49: 151-158.
23. Cryer PE: Mechanisms of hypoglycemia-associated autonomic 
failure in diabetes.  N Engl J Med (2013) 369: 362-372.
24. Kheloufi M,  Boulanger CM,  Durand F and Rautou PE: Liver auto-
phagy in anorexia nervosa and acute liver injury.  Biomed Res Int 
(2014) 2014: 701064.
25. Sakada M,  Tanaka A,  Ohta D,  Takayanagi M,  Kodama T,  Suzuki K,  
Inoue K,  Fujita Y and Maruyama M: Severe steatosis resulted from 
anorexia nervosa leading to fatal hepatic failure.  J Gastroenterol 
(2006) 41: 714-715.
26. Harris RH,  Sasson G and Mehler PS: Elevation of liver function 
tests in severe anorexia nervosa.  Int J Eat Disord (2013) 46: 369-
374.
27. Fukusako T,  Negoro K,  Tsuda N,  Kato M and Morimatsu M: [A 
case of secondary carnitine deficiency due to anorexia nervosa 
and severe liver damage].  Rinsho Shinkeigaku (1995) 35: 34-37 (in 
Japanese).
28. Rebouche CJ and Paulson DJ: Carnitine metabolism and function 
in humans.  Annu Rev Nutr (1986) 6: 41-66.
29. Schorr M and Miller KK: The endocrine manifestations of anorexia 
nervosa: mechanisms and management.  Nat Rev Endocrinol (2017) 
13: 174-186.
30. Takahara J,  Hosogi H,  Yunoki S,  Hashimoto K and Uneki T:  
Hypothalamic pituitary adrenal function in patients with anorexia 
nervosa.  Endocrinol Jpn (1976) 23: 451-456.
31. Gianotti L,  Lanfranco F,  Ramunni J,  Destefanis S,  Ghigo E and 
Arvat E: GH/IGF-I axis in anorexia nervosa.  Eat Weight Disord 
(2002) 7: 94-105.
32. Matsubayashi S,  Tamai H,  Uehata S,  Kobayashi N,  Mori K,  
Nakagawa T and Kumagai LF: Anorexia nervosa with elevated 
serum TSH.  Psychosom Med (1988) 50: 600-606.
636 Yamamoto et al. Acta Med.  Okayama　Vol.  75,  No.  5
